Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001975776-23-000001
Filing Date
2023-05-04
Accepted
2023-05-04 17:21:40
Documents
1
Effectiveness Date
2023-05-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6317
  Complete submission text file 0001975776-23-000001.txt   7345
Mailing Address 3960 BROADWAY, 6TH FLOOR NEW YORK NY 10032
Business Address 3960 BROADWAY, 6TH FLOOR NEW YORK NY 10032 (929) 578-0778
Ancilia Biosciences, Inc. (Filer) CIK: 0001975776 (see all company filings)

EIN.: 834260764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-480881 | Film No.: 23890154